SEC Form 4 · accession 0001179110-15-004510
MERRIMACK PHARMACEUTICALS INC · MACK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert J. Mulroy
Officer — President and CEO · Director
Period of report
Mar 5, 2015
Accepted (ET)
Mar 9, 2015 · 4:16 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001274792
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 5, 2015 | M | 22,385 | $1.71 | A | 1,361,701 | D | |
| Common Stock | Mar 5, 2015 | S | 22,385 | $12.50 | D | 1,339,316 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F2 | $1.71 | Mar 5, 2015 | M | 22,385 | D | — | Aug 3, 2015 | Common Stock | 22,385 | 284,368 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- F2This option is fully vested.